- By Elizabeth Chao, MD, FACMG
- Posted October 17, 2024
The Evolution of Hereditary Cancer Testing: Why Pan-Cancer Panels Are the Future of Genetic Risk Assessment
Hereditary cancer testing has changed dramatically over the past decade, reshaping how healthcare professionals diagnose and manage genetic risks. Initially, testing focused on specific genes like BRCA1 and BRCA2, linked to breast and ovarian cancers. These gene tests were quite limited, only looking at a small set of mutations…
- By Liese Vito, MD
- Posted February 7, 2024
CARE Patient Examples at Lake Health
Many patients are anxious about their family history—more than providers realize. In some cases, they may feel like a ticking time bomb with no options. In Part One of this blog series, I talked about The Ambry CARE ProgramTM and how Lake Health has been able to use it to identify more high-risk patients, increase family history and cancer risk…
- By Liese Vito, MD
- Posted January 24, 2024
Hereditary Cancer Testing with CARE
According to studies, 93% of high-risk women who qualify for breast MRI have not had one.1 97% of women at risk for hereditary breast/ovarian cancer have not had genetic testing.2 These healthcare gaps mean high-risk patients are being missed when it comes to proactive and preventative care. As a practicing OB-GYN for twenty years, I have seen…
- By Ashley Thompson
- Posted September 14, 2023
Ovarian Cancer Awareness Month Spotlight: Norma Livingston Ovarian Cancer Foundation
Norma was a healthy, active 65-year-old woman who was rarely sick and had always been proactive about her health. She went to her internist complaining of weight gain, abdominal discomfort, and a chronic cough. When the diagnosis was finally made, Norma had stage 4 ovarian cancer. She endured nine hours of surgery, countless rounds of chemotherapy,…
- By Catherine Schultz, MS, CGC
- Posted March 23, 2023
Ambry Genetics Diagnostic Dilemma: +RNAinsight® Reveals Lynch Syndrome in Sisters
In recognition of Colon Cancer Awareness Month, Ambry would like to share the story of Jane and Julie Smith (not their real names) – sisters and cancer survivors. Jane was diagnosed with colon cancer in 2004 at the age of 36. While she was concerned about her diagnosis and family history of ovarian cancer, genetic testing was not widely available…
- By Jodi Tahsler
- Posted March 8, 2023
International Women’s Day: Spotlighting Cathrine Keller, MD, A Woman of Substance
Being a “woman of substance” requires a passion for benefitting the greater good. Dr. Cathrine Keller has it in abundance. “We believe the greater good is to put our patients’ health and safety at the epicenter of every decision we make.” A woman of substance seldom has a neutral position. As a leader in the fight against breast cancer,…
- By Layla Shahmirzadi, MS, CGC, LGC
- Posted September 4, 2018
3 Things You Need to Know about OvaNext
Ovarian cancer can often appear quietly, with non-specific symptoms, making it difficult to detect at an early stage. Knowing if someone is at an increased risk for ovarian and other cancers can be critical for guiding early detection, prevention, or treatment. Genetic testing can help identify patients with hereditary cancer, allowing for personalized…
- By Kim Price
- Posted September 18, 2017
Signs and Symptoms of Ovarian Cancer- What you Need to Know
The National Ovarian Cancer Coalition® has been supporting the women, families, and caregivers affected by ovarian cancer for more than 25 years. With 1 in 75 women being diagnosed with the disease, the NOCC is especially focused during the month of September on bringing earlier awareness of the signs and symptoms of the disease to women throughout…
- By Cynthia Rigali Lund
- Posted September 18, 2017
Life After Chemotherapy and Surgery for Ovarian Cancer
September is Ovarian Cancer Awareness Month and it’s a wonderful way to encourage women to create a deeper consciousness about their bodies. As I approach my five-year survivor date—the closest marker we have to saying “cured,” I can say with deepest gratitude how much I appreciate my body and all that it does for me, as well as how much…
- By James L. Wilder, MD
- Posted September 11, 2017
The Benefits of Genetic Testing for Your GYN/ONC Practice
An estimated 22,440 women will be diagnosed with ovarian cancer in 2017. Early detection is critical for successful treatment of this disease, which has a 5-year survival rate of 92.5% for women who are diagnosed with early stage/localized ovarian cancer.1 We hope that Ovarian Cancer Awareness Month will bring more women to their healthcare providers…